Kevin J. Dallas
Known title: DirectorCIK: 0001730784
Kevin J. Dallas's purchase track record
Kevin J. Dallas has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/30/2023 | ALGN | $2.00M | +29.0% | -24.9% | +8.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ALGN | ▲ Buy | Option Exercise | 1,745 | $0 | 5/20/2026 | View on chart |
| ALGN | ▲ Buy | Option Exercise | 1,148 | $0 | 5/21/2025 | View on chart |
| ALGN | ▲ Buy | Option Exercise | 1,029 | $0 | 5/17/2024 | View on chart |
| ALGN | ▲ Buy | Open Market | 7,000 | $2.0M | 5/30/2023 | View on chart |
| ALGN | ▲ Buy | Option Exercise | 1,114 | $0 | 5/17/2023 | View on chart |
| ALGN | ▲ Buy | Option Exercise | 524 | $0 | 5/18/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Align Technology Sets Q3 2026 Earnings Date for October 28
Align Technology has scheduled its third-quarter 2026 earnings release for October 28, 2026. This announcement comes as the stock trades near its 52-week low, prompting market discussions about whether the current valuation is reasonable after a significant decline. Analysts continue to watch the company's position in the dental equipment sector, with average price targets remaining above current levels.
Align Technology Sets Q3 2026 Earnings Date for October 28. Align Technology has scheduled its third-quarter 2026 earnings release for October 28, 2026. This announcement comes as the stock trades near its 52-week low, prompting market discussions about whether the current valuation is reasonable after a significant decline. Analysts continue to watch the company's position in the dental equipment sector, with average price targets remaining above current levels.